Annals of the Rheumatic Diseases

The Annals of the Rheumatic Diseases is a respected medical journal that undergoes peer review. It is jointly published by the BMJ Group and the European League Against Rheumatism. This journal explores various topics within rheumatology, such as musculoskeletal disorders, arthritis, and connective tissue diseases. It features a range of content, including basic, clinical, and translational research, as well as abstracts from relevant conferences. Founded in 1939, the journal is available online through a subscription, while editions older than one year can be accessed for free. Each issue highlights one paper chosen by the editor-in-chief, who is Tore K. Kvien, as an "Editors Choice" and makes it available for open access.

Local

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

N/A

Country

N/A

Articles

Paul Hunter Plotz (1937-2024): renaissance rheumatologist, human rights advocate and mensch

Nov 14, 2024 | ard.bmj.com | Frederick W Miller |John O'Shea |Skin Diseases

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis

Nov 14, 2024 | ard.bmj.com | Hui Wu |Hanmei Yuan |Jin Zhang |Taojun He

Arthritis, RheumatoidAnti-Citrullinated Protein AntibodiesAntibodiesData availability statementData are available on reasonable request.
Rheumatoid arthritis patients harbour aberrant enteric bacteriophages with autoimmunity-provoking potential: a paired sibling study

Nov 14, 2024 | ard.bmj.com | Fanlei Hu |Xin Li |Kai Liu |Yanpeng Li

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. View Full Text Read the full text or download the PDF:
Uncovering specific genetic-respiratory disease endotypes for rheumatoid arthritis risk

Nov 1, 2024 | ard.bmj.com | Vanessa L Kronzer |Katrina A Williamson |Keigo Hayashi |Elizabeth Atkinson

Uncovering specific genetic-respiratory disease endotypes for rheumatoid arthritis risk Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Paraspinal tophi

Oct 21, 2024 | ard.bmj.com | Juan Wu |Yun Zhang

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. GoutArthritisLow Back PainA young adult patient with gout was incidentally found to have a large mass on the right lumbar spine and sacrum during an abdominal CT scan.
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

Oct 21, 2024 | ard.bmj.com | Laure Gossec |Laura Coates |Dafna D Gladman |Jacob A Aelion

Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Correspondence on ‘Current myositis clinical trials and tribulations’ by Saygin et al

Oct 21, 2024 | ard.bmj.com | Sofia Ferreira Azevedo |Antonia Valenzuela |Cristian Alejandro Benitez |David Isenberg

Delayed-start arms, such as in the phase 2 MYOJAK (NCT04208464, testing baricitinib, a JAK 1/2 inhibitor) and ARTEMIS (NCT01315938, testing abatacept, a CTLA-4 analogue that blocks the costimulatory signal mediated by the CD28-CD80/86 pathway) IIM clinical trials, randomise subjects to a briefer placebo-controlled phase either at the beginning or at the end of the trial. All subjects receive treatment which incentivises patient participation.
Correspondence on ‘Current myositis clinical trials and tribulations’ by Saygin et al

Oct 21, 2024 | ard.bmj.com | Sofia Ferreira Azevedo |Antonia Valenzuela |Cristian Alejandro Benitez |David Isenberg

Delayed-start arms, such as in the phase 2 MYOJAK (NCT04208464, testing baricitinib, a JAK 1/2 inhibitor) and ARTEMIS (NCT01315938, testing abatacept, a CTLA-4 analogue that blocks the costimulatory signal mediated by the CD28-CD80/86 pathway) IIM clinical trials, randomise subjects to a briefer placebo-controlled phase either at the beginning or at the end of the trial. All subjects receive treatment which incentivises patient participation.
Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

Oct 21, 2024 | ard.bmj.com | Antonis Fanouriakis |George Bertsias |Dimitrios T. Boumpas

Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al Free Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Referral of patients with suspected polymyalgia rheumatica: how complete is our view of ‘planet PMR?’

Oct 21, 2024 | ard.bmj.com | Dario Camellino |Eric L. Matteson

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.